Cargando…

Elevated Circulating PCSK9 Concentrations Predict Subclinical Atherosclerotic Changes in Low Risk Obese and Non-Obese Patients

INTRODUCTION: Many studies have highlighted the important role of PCSK9 in the development of cardiometabolic changes and its possible function as a biomarker of myocardial infarction or ischemic heart disease. This study aimed to determine the relationship between circulating PCSK9 levels and subcl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tóth, Štefan, Fedačko, Ján, Pekárová, Tímea, Hertelyová, Zdenka, Katz, Matan, Mughees, Adil, Kuzma, Jozef, Štefanič, Peter, Kopolovets, Ivan, Pella, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688969/ https://www.ncbi.nlm.nih.gov/pubmed/28623549 http://dx.doi.org/10.1007/s40119-017-0092-8

Ejemplares similares

Hypothesis of “stroke-stop” formula: a tool for risk index determination in development of acute cerebrovascular disease in asymptomatic individuals with carotid stenosis
por: Kopolovets, Іvan, et al.
Publicado: (2021)

Rare Presentation of Left Lower Lobe Pulmonary Artery Dissection
por: Hako, René, et al.
Publicado: (2017)

Analysis of Risk Factors in Patients with Subclinical Atherosclerosis and Increased Cardiovascular Risk Using Factor Analysis
por: Pella, Zuzana, et al.
Publicado: (2021)

Vaccines Targeting PSCK9 for the Treatment of Hyperlipidemia
por: Toth, Stefan, et al.
Publicado: (2020)

Nuclear factor-kB and nitric oxide synthases in red blood cells: Good or bad in obesity? A preliminary study
por: Široká, Monika, et al.
Publicado: (2020)

Classic and New Markers in Diagnostics and Classification of Breast Cancer
por: Beňačka, Roman, et al.
Publicado: (2022)

Non-Coding RNAs in Human Cancer and Other Diseases: Overview of the Diagnostic Potential
por: Beňačka, Roman, et al.
Publicado: (2023)

Adoption of PCSK9 Inhibitors Among Patients With Atherosclerotic Disease
por: Dayoub, Elias J., et al.
Publicado: (2021)

Association of variants in the PCSK1 gene with obesity in the EPIC-Norfolk study
por: Kilpeläinen, Tuomas O., et al.
Publicado: (2009)

Severe obesity and diabetes insipidus in a patient with PCSK1 deficiency()
por: Frank, Graeme R., et al.
Publicado: (2013)

Hyperphagia and Obesity in Prader–Willi Syndrome: PCSK1 Deficiency and Beyond?
por: Ramos-Molina, Bruno, et al.
Publicado: (2018)

Coenzyme Q10 Modulates Remodeling Possibly by Decreasing Angiotensin-Converting Enzyme in Patients with Acute Coronary Syndrome
por: Singh, Ram B., et al.
Publicado: (2018)

Relationship between Circulating PCSK9 and Markers of Subclinical Atherosclerosis—The IMPROVE Study
por: Coggi, Daniela, et al.
Publicado: (2021)

Association of obesity risk SNPs in PCSK1 with insulin sensitivity and proinsulin conversion
por: Heni, Martin, et al.
Publicado: (2010)

Preferential apelin-13 production by the proprotein convertase PCSK3 is implicated in obesity()
por: Shin, Kyungsoo, et al.
Publicado: (2013)

A novel mutation in the mouse Pcsk1 gene showing obesity and diabetes
por: Muhsin, Nor I. A., et al.
Publicado: (2020)

Markers of subclinical atherosclerotic disease in HIV-infected individuals
por: Gupta, Pulin K, et al.
Publicado: (2018)

Effect of PCSK9 on atherosclerotic cardiovascular diseases and its mechanisms: Focus on immune regulation
por: Ma, Minglu, et al.
Publicado: (2023)

Risk Factors for Subclinical Atherosclerosis in Diabetic and Obese Children
por: Faienza, Maria Felicia, et al.
Publicado: (2013)

Subclinical Atherosclerosis and Obesity Phenotypes Among Mexican Americans
por: Laing, Susan T., et al.
Publicado: (2015)

Subclinical Hypothyroidism among local adult obese population
por: Sami, Abdul, et al.
Publicado: (2018)

Subclinical Hypothyroidism in Danish Lean and Obese Children and Adolescents
por: Dahl, Maria, et al.
Publicado: (2017)

Natural History of Obesity Due to POMC, PCSK1, and LEPR Deficiency and the Impact of Setmelanotide
por: Wabitsch, Martin, et al.
Publicado: (2022)

Variants of PCSK9 Gene Are Associated with Subclinical Atherosclerosis and Cardiometabolic Parameters in Mexicans. The GEA Project
por: Zamarrón-Licona, Erasmo, et al.
Publicado: (2021)

The Effect of PCSK9 Inhibition on the Stabilization of Atherosclerotic Plaque Determined by Biochemical and Diagnostic Imaging Methods
por: Basiak, Marcin, et al.
Publicado: (2023)

Assessment of subclinical atherosclerotic cardiovascular disease in patients with ankylosing spondylitis
por: Hatipsoylu, Erdinç, et al.
Publicado: (2019)

Association of PCSK1 rs6234 with Obesity and Related Traits in a Chinese Han Population
por: Qi, Qibin, et al.
Publicado: (2010)

PCSK1 rs6232 Is Associated with Childhood and Adult Class III Obesity in the Mexican Population
por: Villalobos-Comparán, Marisela, et al.
Publicado: (2012)

Functional and clinical relevance of novel and known PCSK1 variants for childhood obesity and glucose metabolism
por: Löffler, Dennis, et al.
Publicado: (2016)

Association of PCSK1 and PPARG1 Allelic Variants with Obesity and Metabolic Syndrome in Mexican Adults
por: Velazquez-Roman, Jorge, et al.
Publicado: (2023)

Circulating Tryptase as a Marker for Subclinical Atherosclerosis in Obese Subjects
por: Moreno, María, et al.
Publicado: (2014)

Normal-weight obesity is associated with increased risk of subclinical atherosclerosis
por: Kim, Sohee, et al.
Publicado: (2015)

Prevalence of Subclinical Peripheral Vascular Disease in Obese Egyptian Patients
por: Younes, Jehan Ahmed, et al.
Publicado: (2017)

Leptin Levels are Associated with Subclinical Cardiac Dysfunction in Obese Adolescents
por: Imerbtham, Thamonwan, et al.
Publicado: (2020)

Influence of subclinical hypothyroidism on metabolic parameters in obese children and adolescents
por: Kara, Ozlem
Publicado: (2020)

Relationship of subclinical hypothyroidism and obesity in polycystic ovarian syndrome patients
por: Nayak, Prasanta K., et al.
Publicado: (2020)

Association of Fetuin-B with Subclinical Atherosclerosis in Obese Chinese Adults
por: Li, Zhibin, et al.
Publicado: (2020)

Irisin as a Novel Biomarker of Subclinical Atherosclerosis in Severe Obesity
por: Carmona-Maurici, Júlia, et al.
Publicado: (2023)

Atherosclerotic Markers in Obese and Nonobese Children and Relationship with Nighttime Hypertension
por: Agilli, Mehmet, et al.
Publicado: (2014)

Investigation of highly expressed PCSK9 in atherosclerotic plaques and ox-LDL-induced endothelial cell apoptosis
por: Li, Jiao, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ahpoh630cjhhvhjtm88q2fkmvh